Russian Extreme Hypertriglyceridemia Registry
Key facts
- Who runs it
- Russian Cardiology Research and Production Center
- Where
- Russia6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 20 Nov 2025
- Expected to end
- Dec 2045
- Type of study
- Observational
- Record updated
- 2 April 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L), confirmed by at least two independent measurements
- Written informed consent from the patient or legal guardian
- No age restrictions
Who cannot take part
- Patients whose extreme hypertriglyceridemia is caused by alcohol abuse, uncontrolled diabetes, or other medical conditions, unless extreme hypertriglyceridemia is confirmed after controlling the underlying condition
- Lack of informed consent
This trial is currently available in Russia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.
The group in the trial
- Extreme Hypertriglyceridemia
Patients with triglyceride levels ≥10 mmol/L, confirmed by at least two independent measurements, under the care of participating lipid centers in the Russian Federation.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Russian Extreme Hypertriglyceridemia Registry (REGGI)
- Record updated
- 2 April 2026